1. Home
  2. CHOW vs BLRX Comparison

CHOW vs BLRX Comparison

Compare CHOW & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ChowChow Cloud International Holdings Limited Ordinary Shares

CHOW

ChowChow Cloud International Holdings Limited Ordinary Shares

BUY

Current Price

$0.30

Market Cap

12.3M

Sector

Technology

ML Signal

BUY

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

BUY

Current Price

$2.08

Market Cap

11.7M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CHOW
BLRX
Founded
2014
2003
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.3M
11.7M
IPO Year
2024
2010

Fundamental Metrics

Financial Performance
Metric
CHOW
BLRX
Price
$0.30
$2.08
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 6.5M
14.6K
Earning Date
05-15-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$37.33
Revenue Next Year
N/A
$37.06
P/E Ratio
$10.80
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$1.95
52 Week High
$12.05
$3.95

Technical Indicators

Market Signals
Indicator
CHOW
BLRX
Relative Strength Index (RSI) 34.57 25.46
Support Level $0.36 N/A
Resistance Level $0.47 $2.56
Average True Range (ATR) 0.11 0.15
MACD -0.02 -0.02
Stochastic Oscillator 1.69 8.04

Price Performance

Historical Comparison
CHOW
BLRX

About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares

ChowChow Cloud International Holdings Ltd provides one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey, from consulting, deployment, and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment, (ii) professional IT services comprising capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations, including infrastructure applications.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: